Quadrant Biosciences and SUNY Upstate Medical University have been chosen as recipients of MedTech’s 2020 Project of the Year award for the development of the Clarifi COVID-19 saliva test.
The award recognizes an initiative that has had a “singular and demonstrable positive impact on public health.” The Clarifi COVID-19 saliva test was co-developed by Quadrant and SUNY Upstate and was recently listed as the most sensitive saliva test on the market by the FDA.
According to MedTech Executive Director Winthrop Thurlow, the Clarifi COVID-19 saliva test “leapt off the page,” when the organization was considering its annual honors.
“It was really the stand-out project of the year,” Thurlow said. “One of the criteria is the project should have a significant impact on the industry in New York or the advancement of healthcare in New York state.
When we look at the Upstate/Quadrant partnership we really saw that as a significant advancement over the last year in the delivery of healthcare. And it clearly won’t be limited to the residents of New York state, it has worldwide potential.”
MedTech, a state-wide trade association based in New York, is made of more than 100 pharmaceutical, biotech and medical technology companies, their suppliers and services providers, and research universities.
MedTech’s 2020 Honors Ceremony will be Thursday, January 14, 2021, from 4-5pm. Interested attendees can register for the event by clicking here.